Society For Risk Analysis Annual Meeting 2017
Session Schedule & Abstracts
* Disclaimer: All presentations represent the views of the authors, and not the organizations that support their research. Please apply the standard disclaimer that any opinions, findings, and conclusions or recommendations in abstracts, posters, and presentations at the meeting are those of the authors and do not necessarily reflect the views of any other organization or agency. Meeting attendees and authors should be aware that this disclaimer is intended to apply to all abstracts contained in this document. Authors who wish to emphasize this disclaimer should do so in their presentation or poster. In an effort to make the abstracts as concise as possible and easy for meeting participants to read, the abstracts have been formatted such that they exclude references to papers, affiliations, and/or funding sources. Authors who wish to provide attendees with this information should do so in their presentation or poster.
|Chair(s): Lisa Robinson firstname.lastname@example.org
Sponsored by Economics and Benefits Analysis Specialty Group and Society for Benefit-Cost Analysis
|Foundations, international organizations, government agencies and others are inter¬≠ested in investing to improve the well-being of populations in low- and middle-income countries. However, choosing which initia¬≠tives to fund and what level of resources to devote to each involves difficult choices. If well-conducted, benefit-cost analysis provides important and useful information to support these decisions.|
To increase the comparability of these analyses, improve their quality, and expand their use, the Bill and Melinda Gates Foundation is supporting the development of guidelines for economic evaluation (https://sites.sph.harvard.edu/bcaguidelines/). These guidelines are designed to encourage completion of high-quality, transparent, and consistent evaluations that address the needs of decision-makers and other stakeholders.
This session provides an opportunity to learn more about the development of these guidelines and to offer feedback on their content, aiding in shaping the ultimate recommendations. We will provide an overview of the project and summarize our work to-date, then discuss selected methodological topics in more detail. These include draft recommendations for valuing reductions in fatal and nonfatal risks and for using economy-wide (computable general equilibrium) models to estimate impacts. The final recommendations will ultimately be incorporated into easy-to-use, step-by-step guidance. After brief presentations and comments from discussants, we will allow substantial time for feedback from the audience.
Presenters: Lisa A. Robinson and James K. Hammitt (Harvard Center for Health Decision Science and Center for Risk Analysis), James E. Neumann (Industrial Economics, Incorporated), Maureen Cropper (University of Maryland), Chris Dockins (U.S. Environmental Protection Agency), Urvashi Narain (The World Bank), and Sandra Hoffmann (U.S. Department of Agriculture)
[back to schedule]